These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23439633)
1. The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain. Ehrhardt K; Davioud-Charvet E; Ke H; Vaidya AB; Lanzer M; Deponte M Antimicrob Agents Chemother; 2013 May; 57(5):2114-20. PubMed ID: 23439633 [TBL] [Abstract][Full Text] [Related]
2. The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites. Ehrhardt K; Deregnaucourt C; Goetz AA; Tzanova T; Gallo V; Arese P; Pradines B; Adjalley SH; Bagrel D; Blandin S; Lanzer M; Davioud-Charvet E Antimicrob Agents Chemother; 2016 Sep; 60(9):5146-58. PubMed ID: 27297478 [TBL] [Abstract][Full Text] [Related]
3. Investigating the mode of action of the redox-active antimalarial drug plasmodione using the yeast model. Mounkoro P; Michel T; Blandin S; Golinelli-Cohen MP; Davioud-Charvet E; Meunier B Free Radic Biol Med; 2019 Sep; 141():269-278. PubMed ID: 31238126 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum. Painter HJ; Morrisey JM; Vaidya AB Antimicrob Agents Chemother; 2010 Dec; 54(12):5281-7. PubMed ID: 20855748 [TBL] [Abstract][Full Text] [Related]
5. Exploring the trifluoromenadione core as a template to design antimalarial redox-active agents interacting with glutathione reductase. Lanfranchi DA; Belorgey D; Müller T; Vezin H; Lanzer M; Davioud-Charvet E Org Biomol Chem; 2012 Jun; 10(24):4795-806. PubMed ID: 22618151 [TBL] [Abstract][Full Text] [Related]
6. Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs. Cobbold SA; Chua HH; Nijagal B; Creek DJ; Ralph SA; McConville MJ J Infect Dis; 2016 Jan; 213(2):276-86. PubMed ID: 26150544 [TBL] [Abstract][Full Text] [Related]
7. Methylene blue as an antimalarial agent. Schirmer RH; Coulibaly B; Stich A; Scheiwein M; Merkle H; Eubel J; Becker K; Becher H; Müller O; Zich T; Schiek W; Kouyaté B Redox Rep; 2003; 8(5):272-5. PubMed ID: 14962363 [TBL] [Abstract][Full Text] [Related]
8. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses. Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352 [TBL] [Abstract][Full Text] [Related]
9. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Atamna H; Krugliak M; Shalmiev G; Deharo E; Pescarmona G; Ginsburg H Biochem Pharmacol; 1996 Mar; 51(5):693-700. PubMed ID: 8615907 [TBL] [Abstract][Full Text] [Related]
10. Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum. Garavito G; Bertani S; Rincon J; Maurel S; Monje MC; Landau I; Valentin A; Deharo E Parasite; 2007 Jun; 14(2):135-40. PubMed ID: 17645185 [TBL] [Abstract][Full Text] [Related]
11. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds. Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296 [TBL] [Abstract][Full Text] [Related]
12. Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action. Haynes RK; Cheu KW; Chan HW; Wong HN; Li KY; Tang MM; Chen MJ; Guo ZF; Guo ZH; Sinniah K; Witte AB; Coghi P; Monti D ChemMedChem; 2012 Dec; 7(12):2204-26. PubMed ID: 23112085 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015. Fall B; Madamet M; Diawara S; Briolant S; Wade KA; Lo G; Nakoulima A; Fall M; Bercion R; Kounta MB; Amalvict R; Benoit N; Gueye MW; Diatta B; Wade B; Pradines B Int J Antimicrob Agents; 2017 Aug; 50(2):155-158. PubMed ID: 28689867 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo properties of ellagic acid in malaria treatment. Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Famin O; Ginsburg H Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690 [TBL] [Abstract][Full Text] [Related]
16. The phenothiazinium chromophore and the evolution of antimalarial drugs. Wainwright M; Amaral L Trop Med Int Health; 2005 Jun; 10(6):501-11. PubMed ID: 15941412 [TBL] [Abstract][Full Text] [Related]
17. Interactions of the antimalarial drug methylene blue with methemoglobin and heme targets in Plasmodium falciparum: a physico-biochemical study. Blank O; Davioud-Charvet E; Elhabiri M Antioxid Redox Signal; 2012 Aug; 17(4):544-54. PubMed ID: 22256987 [TBL] [Abstract][Full Text] [Related]
18. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action. Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071 [TBL] [Abstract][Full Text] [Related]
19. Aminonaphthoquinones--a novel class of compounds with potent antimalarial activity against Plasmodium falciparum. Kapadia GJ; Azuine MA; Balasubramanian V; Sridhar R Pharmacol Res; 2001 Apr; 43(4):363-7. PubMed ID: 11352541 [TBL] [Abstract][Full Text] [Related]
20. Verapamil-Sensitive Transport of Quinacrine and Methylene Blue via the Plasmodium falciparum Chloroquine Resistance Transporter Reduces the Parasite's Susceptibility to these Tricyclic Drugs. van Schalkwyk DA; Nash MN; Shafik SH; Summers RL; Lehane AM; Smith PJ; Martin RE J Infect Dis; 2016 Mar; 213(5):800-10. PubMed ID: 26503982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]